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involved in many fundamental cellular responses such as
growth, death, movement, transcription and excitation.
Their roles in human stem cell neural specialization are
not well understood. In this study, we aimed to identify
GPCRs that may play a role in the diﬀerentiation of human
embryonic stem cells (hESCs) to neural stem cells (NSCs).
Using a feeder-free hESC neural diﬀerentiation protocol,
we found that the expression of several chemokine recep-
tors changed dramatically during the hESC/NSC transition.
Especially, the expression of CXCR4 increased approxi-
mately 50 folds in NSCs compared to the original hESCs.
CXCR4 agonist SDF-1 promoted, whereas the antagonist
AMD3100 delayed the neural induction process. In consis-
tence with antagonizing CXCR4, knockdown of CXCR4 in
hESCs also blocked the neural induction and cells with
reduced CXCR4 were rarely positive for Nestin and Sox1-
staining. Taken together, our results suggest that CXCR4
is involved in the neural induction process of hESC and it
might be considered as a target to facilitate NSC production
from hESCs in regenerative medicine.  2016 The Authors.
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Human embryonic stem cells (hESCs) hold enormous
promise for regenerative medicine and disease
modeling (Wobus and Boheler, 2005). Directed diﬀerenti-
ation of hESCs to speciﬁc lineages has been a focal point
in the ﬁeld of hESC research. In vitro diﬀerentiation of
hESCs toward deﬁned neuronal and glial lineages
(Dhara and Stice, 2008; Erceg et al., 2009) not only oﬀers
a great opportunity to study neurodevelopment and model
neurological disease at cellular level, it also holds the
potential for the treatment of neurodegenerative diseases
and brain injuries (Hedlund and Perlmann, 2009). The
seven-transmembrane G protein-coupled receptors
(GPCRs) belong to the largest cell surface receptor fam-
ily; however, they are poorly investigated in hESC diﬀer-
entiation. GPCRs can detect a diversity of ligands and
initiate intracellular signaling primarily via activation of
intracellular G proteins (Granier and Kobilka, 2012), and
they are involved in fundamental cellular responses such
as growth, death, movement, transcription and excitation
(Zhang and Xie, 2012). Many GPCRs have been found to
play important roles in embryonic development
(Kobayashi et al., 2010). But detailed information about
their expression and functions during the neural special-
ization of hESCs is still lacking.
Chemokine receptors are GPCRs that interact with a
type of cytokine called chemokines. They play critical
roles in traﬃcking the cells to desired locations, a
process named chemotaxis, along the chemokine
gradient (Nieto et al., 1997). The involvement of the che-
mokine/chemokine receptor family in central nervous sys-
tem (CNS) development and neurogenesis has been
reported (Bonavia et al., 2003; Doze and Perez, 2012).
For example, CXCR4 and its ligand CXCL12, also named
stromal cell-derived factor 1 (SDF-1), are highly
expressed in the cerebellum, hippocampus, and neocor-
tex and also constitutively expressed in the brain during
adulthood (Kolodziej et al., 2008). The interaction
between CXCR4 and SDF-1 has been strongly suggested
to be important in neuronal development and patterning of
the cerebellum and hippocampus in the rodent brain (Ma
et al., 1998; Lu et al., 2002). CXCR4 is highly expressed
in human neural precursor cells (NPCs) (Ni et al., 2004).
SDF-1 also increases human NPC proliferation (Wuons.org/licenses/by-nc-nd/4.0/).
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ment (Li et al., 2010; Merino et al., 2015). Most of the
studies so far focused on the chemotaxis eﬀect of chemo-
kine receptors to drive cell migration during neural devel-
opment, mostly after the neural stem cell (NSC) stage.
How chemokine receptors function during the process of
neural induction of hESC remains elusive.
Here we sought to identify the role of GPCRs in the
neural induction process of hESCs. Using a PCR array,
we found signiﬁcant upregulation of CXCR4 expression
upon hESCs to NSCs transition. Activation of CXCR4
by its agonist SDF-1 facilitated NSC generation from
hESCs, whereas either antagonizing CXCR4 with its
antagonist or downregulation of CXCR4 with RNAi gave
the opposite eﬀect. Taken together, we found that
CXCR4 plays an important role in hESC neural
induction process, and agents activating CXCR4 might
be used to facilitate eﬃcient NSC production from hESCs.
EXPERIMENTAL PROCEDURES
hESC culture
hESCs (H9 cell line) (Amit et al., 2000) were cultured
under feeder-free conditions in mTeSR1 (STEMCELL
Technologies, Vancouver, British Columbia, Canada).
hESCs were plated on the hESC-qualiﬁed Matrix (BD
Bioscience, San Diego, CA, USA)-coated culture vessels
and passaged every 3–4 days using 0.5 mM EDTA for
5–10 min at 37 C.
Neural induction and diﬀerentiation
When reaching nearly conﬂuent state, hESCs were
passaged using accutase (Life Technology, Grand
Island, NY, USA) and plated onto Geltrex LDEV-Free
hESC-qualiﬁed Reduced Growth Factor Basement
Membrane Matrix (Life Technology, Grand Island, NY,
USA) -coated culture vessels. Cells were treated
overnight with the ROCK inhibitor Y-27632 (Sigma–
Aldrich, St Louis, MO, USA) to increase cell survival. On
day 1 after hESC splitting (about 15–25% conﬂuence),
the mTeSR1 medium was aspirated and cells were
cultured in Neural Induction Medium (Life Technology,
Grand Island, NY, USA) for 7 days to obtain NSCs.
Spontaneous diﬀerentiation was performed in Neural
Diﬀerentiation Medium (Neural Basal Medium, 1  N2,
1  B27 (Life Technology, Grand Island, NY, USA), 10
nM dibutyryl cAMP (Sigma, St Louis, MO, USA),
200 ng/ml Ascorbic acid (Sigma, St Louis, MO, USA),
1 ng/ml BDNF (PeproTech, Rocky Hill, NJ, USA), 1 ng/
ml GDNF (PeproTech, Rocky Hill, NJ, USA), 1 ng/ml
IGF-1 (PeproTech, Rocky Hill, NJ, USA)) on laminin-
coated surface. 14–16 days later, cells were ﬁxed and
stained for neuronal or glial marker.
Real-time PCR
Total RNA was isolated using Trizol (Life Technology,
Grand Island, NY, USA) and 2 lg RNA was used to
synthesize cDNA using the M-MLV Reverse
Transcriptase and Recombinant RNasin RibonucleaseInhibitor (Promega, Madison, WI, USA) according to the
manufacturer’s instruction. Real-time PCR was
performed using FastStart Universal Probe Master Mix
(Roche, Basel, Switzerland) and analyzed with a
Stratagene Mx 3000P thermal cycler (Agilent). A relative
standard curve method was used to analyze the relative
quantitation of gene expression during hESC
diﬀerentiation. Two series of real-time PCR reactions
were prepared to quantify both the target and the
control gene ACTB. Standard curves were generated
using a 5 to 10-fold serial dilution of cDNA pool of hESC
and NSC samples. Simultaneously, all experimental
samples were subjected to PCR ampliﬁcation and the
expression level of target genes or ACTB was
determined by interpolating from their standard curve
respectively. The expression level of a target gene in
one experimental sample was normalized by its ACTB
level ﬁrst, and then expressed as a relative expression
or a fold-change between diﬀerent samples. The real-
time PCR primer sequences were listed in Table 1.Alkaline phosphatase and immunoﬂuorescent
staining
For alkaline phosphatase (AP) staining, hESCs were
ﬁxed with 4% paraformaldehyde (PFA) in PBS for 40 s,
rinsed once with PBS and stained using a leukocyte
alkaline phosphatase kit (Sigma–Aldrich, St Louis, MO,
USA) according to the manufacturer’s protocol. For
immunoﬂuorescent staining, cells were ﬁxed with 4%
PFA for 15 min. The ﬁxed cells were washed with PBS
and incubated in 0.2% Triton X-100 for 20 min, then
washed with PBS and incubated in blocking buﬀer
containing 20% FBS, 10% Glycerol, 100 nM Glycine
and 0.1% Triton X-100 for 30 min at room temperature.
The cells were then incubated with primary antibodies
against Oct4 (Abcam, ab19857), SSEA-4 (Millipore,
MAB4304), Nanog (Abcam, ab21624), Nestin (Millipore,
MAB5326), Sox2 (Abcam, ab15830), Sox1 (Abcam,
ab22572), Pax6 (DSHB, P3U1), Musashi1 (Abcam,
ab21628), Tuj1 (Covance, PRB-435P), GFAP
(Invitrogen, 13-0300) or O4 (R&D, MAB1326) overnight
at 4 C. The following day cells were washed with PBS
and incubated in the appropriate secondary antibodies
conjugated to Alexa Fluor 546 or Alexa Fluor 488
(Invitrogen) for one hour at room temperature. Nuclei
were counterstained with Hoechst 33342 for 10 min.
Images were taken with an Olympus IX71 inverted
ﬂuorescent microscope or an Olympus FV10i confocal
microscope.RNA interference in hESCs
For lentivirus-mediated CXCR4 knockdown, lentiviral
vector FG12 (derived from the pFUGW vector,
Addgene) and packaging plasmids pRSV/REV, pMDLG/
pRRE and pHCMVG were used. To construct the
shRNA expression cassette, complementary DNA
oligonucleotides were synthesized, annealed and
inserted immediately downstream of the U6 promoter of
the pBS/U6 plasmid, and the derived cassette was
Table 1. Primers used in real-time PCR analysis.
Gene Forward primer Reverse primer
ACTB 50-TGAAGTGTGACGTGGACATC-30 50-GGAGGAGCAATGATCTTGAT-30
Oct4 50-ATGTGGTCCGAGTGTGGTTC-30 50-GAGACAGGGGGAAAGGCTTC-30
Nanog 50-CAGAAGGCCTCAGCACCTAC-30 50-GGCCTGATTGTTCCAGGATT-30
Sox2 50-AGCTACAGCATGATGCAGGA-30 50-GGTCATGGAGTTGTACTGCA-30
Nestin 50-GCGTTGGAACAGAGGTTGGA-30 50-TGGGAGCAAAGATCCAAGAC-30
Sox1 50-CCTCCGTCCATCCTCTG-30 50-AAAGCATCAAACAACCTCAAG-30
Pax6 50-CTGAAGCGGAAGCTGCAAAG-30 50-TTGCTGGCCTGTCTTCTCTG-30
Musashi1 50-GCTCAGCCAAAGGAGGTGAT-30 50-GCGTAGGTTGAGGCTTGGAA-30
CXCR1 50-CGCCTATGCCCTAGTGTTCC-30 50-AAAATCCAGCCATTCACCTT-30
CXCR2 50-GACCCAGGTGATCCAGGAGA-30 50-GCCCTGAAGAAGAGCCAACA-30
CXCR3 50-CCCTCTACAGCCTCCTCTTTC-30 50-ACTATGTTCAGGTAGCGGTCAAA-30
CXCR4 50-CCCTCCTGCTGACTATTCCC-30 50-TAAGGCCAACCATGATGTGC-30
CXCR5 50-GTCACCCTACCACATCGTCATC-30 50-GTACAGCCCAGCTTCGTCAG-30
CXCR6 50-ACAGAGGCCATCGCATACC-30 50-GAGGCAACCAATGTCCTTCAC-30
CXCR7 50-CAACCTCTTCGGCAGCATTT-30 50-AGACGACACGGCGTACCAT-30
CCR1 50-CAGCCTTCACTTTCCTCACG-30 50-AACGGACAGCTTTGGATTTCTT-30
CCR2 50-TACGGTGCTCCCTGTCATAAA-30 50-CATTCCCAAAGACCCACTCAT-30
CCR3 50-TCTCCCTCTGCTCGTTATGG-30 50-GATGCTTGCTCCGCTCACA-30
CCR4 50-GAAGAAGAACAAGGCGGTGAA-30 50-TGATGGGATTAAGGCAGCAGT-30
CCR5 50-GAGACTCTTGGGATGACGCAC-30 50-CATTTGCAGAAGCGTTTGG-30
CCR6 50-TCCTCATAACATGGTCCTGCTT-30 50-CTCACTGGTCTGCCGAGAAAT-30
CCR7 50-CCATGACCGATACCTACCTGC-30 50-AAAGTGGACACCGAAGACCC-30
CCR8 50-TGGGTGTTTGGGACTGTAATG-30 50-ATCTTCAGAGGCCACTTGGTA-30
CCR9 50-ACAGCCAAATCAAGGAGGAAT-30 50-TAGGGAAACTGAGACAAGACAAAGA-30
CCR10 50-AGGGCTGGAGTCTGGGAAGT-30 50-AGCGGTCGGCGCTGATA-30
SDF-1 50-ACTCCAAACTGTGCCCTTCA-30 50-CCACTTTAGCTTCGGGTCAAT-30
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simultaneously a GFP reporter gene. Recombinant
lentiviruses were produced in HEK-293T cells. hESCs
were infected overnight with lentiviral supernatants, and
GFP+ clones representing infected cells were selected
48–72 h after infection for analyzing the mRNA
expression by real-time PCR or the protein expression
by western blotting using an anti-CXCR4 antibody
(abcam, ab124824). The RNAi sequence targeting
CXCR4 was 50-GGCAGTCCATGTCATCTAC-30 and
50-CTGGTCATGGGTTACCAGA-30. The scrambled
shRNA sequence was 50-GAAGCAGCACGACTTCTTC-30.Statistical analysis
Values are reported as mean ± SEM. Statistical
signiﬁcance (P value) was determined using the paired
Student’s t-test. All graphs were plotted using the
GraphPad Prism 5 software.RESULTS
Neural induction of hESCs and characterization of
hESC-derived NSCs
In order to investigate the role of GPCRs in the neural
induction of hESCs, we ﬁrst set up a neural induction
and diﬀerentiation system using feeder-free hESCs.
hESCs cultured under the feeder-free condition grew
into large compact colonies with clear and smooth edge,
and showed strong alkaline phosphatase staining
(Fig. 1A). Immunostaining of the pluripotency markers
(Klimanskaya et al., 2006) revealed that all colonies
expressed surface antigen SSEA4, as well as thetranscription factors Oct4 and Nanog (Fig. 1B). These
cells were then seeded onto matrigel-coated vessels
and subjected to neural speciﬁcation for the next 7 days
in neural induction medium. Under such conditions,
hESCs were converted into cells exhibited homogenous
neuronal epithelial morphology (Fig. 1C). The derived
cells were characterized by real-time PCR analysis for
the expression of NSC markers (Gage, 2000; Yuan
et al., 2011). Compared to hESCs, several NSC genes,
including Nestin, Musashi1, Sox1, Sox2 and Pax6, were
signiﬁcantly upregulated in the derived cells, whereas
the pluripotency genes Oct4, Nanog and Rex1 were
downregulated (Fig. 1D). Consistently, immunostaining
revealed that the derived NSCs homogenously expressed
Nestin, Sox2, Musashi1 and Pax6 (Fig. 1E). These NSCs
can further spontaneously diﬀerentiate into Tuj1-positive
neurons and GFAP-positive astrocytes (Fig. 1F, G) once
cultured for 14 days in neural diﬀerentiation medium.
O4-positive Oligodendrocytes can be detected on day
16 under such conditions (Fig. 1G). These data suggest
successful transition from hESCs to NSCs.
Expression pattern of chemokine receptors in hESCs
and NSCs
To investigate whether GPCRs are involved in the neural
induction of hESCs, we compared the expression proﬁles
of GPCRs in hESCs and hESC-derived NSCs using a
Taqman PCR array. The array results showed
GPR56, CD97, and the frizzled receptors, such as
FZD1, FZD2 and FZD10 were upregulated upon
transition from hESCs to NSCs (data not shown). These
results are in consistence with previous publications
which showed GPR56 was highly expressed in neural
Fig. 1. Neural induction of hESCs and characterization of hESC-derived NSCs. (A) Morphology and alkaline phosphatase staining of hESCs (Scale
bar = 100 lm). (B) Immunoﬂuorescent staining of pluripotency markers (Oct4, Nanog and SSEA4) in hESCs (Scale bar = 10 lm). (C) Morphology
of cells on day 1, day 3, day 5 and day 7 during neural induction. (Scale bar = 100 lm). (D) Quantitative RT-PCR analysis of gene expression of
neural markers and pluripotency markers in hESCs and NSCs derived from hESCs. The data are mean ± SEM (n= 6). **P< 0.01, ***P< 0.001,
versus hESCs. (E) Immunoﬂuorescent staining of neural markers (Nestin, Sox2, Musashi1 and Pax6) in NSCs derived from hESCs (Scale
bar = 10 lm). (F) Morphology of spontaneously diﬀerentiated NSCs (Scale bar = 100 lm). (G) Immunoﬂuorescent staining of markers for neuron
(Tuj-1), astrocyte (GFAP) and oligodendrocyte (O4) in spontaneously diﬀerentiated NSCs (Scale bar = 10 lm).
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functional in neural induction (Yan et al., 2009; Yu et al.,
2010), indicating the reliability of our assay. We also
found that CXCR4, a chemokine receptor, was
signiﬁcantly upregulated after diﬀerentiation of hESCs to
NSCs. Given the well-known roles of chemokines in cell
migration during embryo development (Raz and
Mahabaleshwar, 2009), we wondered how the other
chemokine receptors behave in the neural diﬀerentiationprocess. Therefore, we examined the expression of 17
chemokine receptors (CCR1 to CCR10, CXCR1 to
CXCR7) and SDF-1 by PCR. The semi quantitative
RT-PCR results demonstrated a signiﬁcantly increased
expression of CCR1, CCR6, CCR7, CXCR4, CXCR5
and CXCR7 upon transition from hESCs to NSCs. In con-
trast, CCR9, CXCR2 and SDF-1 were downregulated
(Fig. 2A). Similar results were obtained with quantitative
real-time PCR analysis (Fig. 2B). Interestingly, the most
Fig. 2. Expression pattern of chemokine receptors in hESCs and hESC-derived NSCs. (A) RT-PCR analysis for chemokine receptor gene
expression in hESCs and hESC-derived NSCs. (B) Real-time PCR analysis of chemokine receptor in hESCs and hESC-derived NSCs. The data are
mean ± SEM (n= 3). *P< 0.05, **P< 0.01, ***P< 0.001, versus hESCs.
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SDF-1. CXCR4 and CXCR7 are two closely related che-
mokine receptors and their expression increased approx-
imately 50 and 20 folds, respectively, in NSCs compared
to the original hESCs (Fig. 2B). SDF-1, the ligand for both
CXCR4 and CXCR7, decreased around 7 folds. It has
been reported that SDF-1 and CXCR4 were involved in
neurogenesis processes such as NPC migration,
proliferation, and diﬀerentiation (Peng et al., 2007; Miller
et al., 2008). Whether and how CXCR4 is involved in
hESC-NSC transition process remains elusive. Our
observation suggested that CXCR4 might be an important
regulator in this process. Therefore, we focused on
CXCR4 in our subsequent studies.Activation of CXCR4 accelerates neural induction of
hESCs
To demonstrate the functional signiﬁcance of increased
expression of CXCR4 during neural induction, we tested
whether activation of CXCR4 can inﬂuence the hESC to
NSC transition. We monitored the progression of neural
induction by immunostaining of Nestin, the most well-
deﬁned marker for NSCs. In vehicle-treated cells, almost
no Nestin-positive cells could be observed on day 2 (data
not shown) and very few Nestin-positive areas (less than
3%) could be seen on day 3 of induction (Fig. 3A, C).
The percentage of Nestin-positive area increased toabout 15% on day 4 and reached a plateau on day 7
(Fig. 3A, C, Ctl). When adding CXCR4 agonist SDF-1 in
the neural induction medium, 3% of the cell area could
already be detected as Nestin-positive on day 2 (data not
shown) and the percentage reached 8% and 20% on day
3 and day 4, respectively (Fig. 3A, C, SDF-1).
Conversely, in the presence of AMD3100, a speciﬁc
antagonist of CXCR4, the neural induction process was
signiﬁcantly delayed. Almost no Nestin-positive area
appeared on day 3 and only about 3% of the cell area
appeared Nestin-positive on day 4 of the neural induction
(Fig. 3A, C, AMD3100). Alternatively, cells were stained
for Sox1, another common marker for NSCs (Li et al.,
2005; Suter et al., 2009), and similar results were obtained
(Fig. 3B, D). In vehicle-treated cells, less than 5% Sox1-
positive cells can be seen on day 3 of induction. The per-
centage of Sox1-positive cells increased to about 10%
on day 4 and reached 80% on day 7 (Fig. 3B, D, Ctl). Cells
treated with SDF-1 showed accelerated protein expres-
sion of Sox1 and 10% of the cells can already be detected
as Sox1-positive on day 3 and the percentage reached
about 20% and 40% on day 4 and day 5 respectively
(Fig. 3B, D, SDF-1). In contrast, blocking CXCR4 with
AMD3100 retarded the Sox1 protein expression during
neural induction of hESCs. Almost no Sox1-postive cells
appeared on day 3 and only 5–10% of the cells appeared
Sox1-positive on day 4 and 5 during the neural induction
(Fig. 3B, D, AMD3100).
Fig. 3. Ligands of CXCR4 aﬀect neural induction of hESCs. (A, B) Immunoﬂuorescent staining of Nestin (A) or Sox1 (B) on day 3–7 of neural
induction of hESCs in control condition (Ctl), or in the presence of CXCR4 agonist SDF-1 (100 nM), or CXCR4 antagonist AMD3100 (100 nM)
(Scale bar = 10 lm). (C, D) Statistical analysis of the percent of nestin-positive area (C) presented in (A) or Sox1-positive cell number (D)
presented in (B). The data are mean ± SEM (n= 10). *P< 0.05, **P< 0.01, ***P< 0.001, versus Ctl.
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of hESCs
Since activation of CXCR4 promotes neural induction of
hESCs, it’s conceivable that downregulation of CXCR4
expression might inhibit neural induction. A shRNA-
based technique was employed to speciﬁcally
knockdown the CXCR4 gene in hESCs and we
monitored the progression of neural induction by
immunostaining of Nestin. The transfection eﬃciency
was monitored by a GFP reporter gene embedded in
the shRNA expression vectors. The knockdown
eﬃciency of two independent shRNAs targeting CXCR4
was tested by real-time PCR and both led to at least
60% downregulation in mRNA level (Fig. 4A). The
downregulation of CXCR4 protein was also approved by
western blot analysis (Fig. 4B). Interestingly,
downregulation of CXCR4 changed the morphology of
hESCs remarkably; however, the pluripotent marker
Oct4 remained unchanged in these cells (Fig. 4C). In
the scramble shRNA transfected cells, around 3%Nestin-positive cell area could be seen on day 3 of
induction, and the percentage of Nestin-positive area
increased to nearly 10% on day 4 and reached more
than 30% on day 6 (Fig. 5A, C, scramble). In contrast,
the progression of neural induction was signiﬁcantly
delayed in CXCR4-knockdown cells and the percentage
of Nestin-positive area remained only half of that in the
scramble shRNA transfected cells until day 6
(Fig. 5A, C, shRNA-1 and -2). Very interestingly, when
using GFP ﬂuorescence to identify CXCR4 shRNA-
transfected cells, we found almost none of the
GFP-positive cells were Nestin-positive (Fig. 5B,
shRNA-1 and -2, cells in white cycles), whereas in cells
transfected with scramble shRNA, much more cells are
Nestin and GFP double positive (Fig. 5B, scramble). We
also did statistic analysis of the cell percentage
expressing Nestin in GFP-positive cells during neural
induction process. As shown in Fig. 5D, in CXCR4
shRNA transfected cells, less than 20% of GFP-positive
cells expressed Nestin, whereas in the scramble group
Fig. 4. Knockdown of CXCR4 in hESCs. (A) Real-time PCR analysis of knockdown eﬃciency of shRNA targeting CXCR4. The data are mean
± SEM (n= 3), ***P< 0.001, versus scramble. (B) Representative western blot analysis of CXCR4 protein level after shRNA expression in hESCs.
(C) Morphology of hESCs expressing scramble or CXCR4 shRNA (left panel) (Scale bar = 100 lm). Immunoﬂuorescent staining of pluripotent
marker Oct4 in hESCs expressing scramble or CXCR4 shRNA (right panel) (Scale bar = 10 lm).
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was stained in these cells (Fig. 6). In consistent with the
Nestin data, knock-down of CXCR4 suppressed Sox1
expression (Fig. 6A, C) and much less GFP/Sox1
double-positive cells can be detected (Fig. 6B, D, cells
in white dashed-line cycles are mostly GFP-positive but
Sox1-negative). Taken together, our results support that
CXCR4 plays an important role in neural induction of
hESCs.DISCUSSION
GPCRs belonging to one of the most important drug
target families have always been the focus of research
in life science. Their functions in stem cell biology
(Callihan et al., 2011) and neurogenesis (Doze and
Perez, 2012) have attracted great attention recently.
Involvement of several GPCRs in neural development
has been reported. For example, LPA inhibits neuronal
diﬀerentiation of NSCs derived form hESCs via LPA
receptors (Dottori et al., 2008). S1P induces proliferation
and a morphological change of NSCs via S1P receptors
(Harada et al., 2004). GPR56 is highly expressed in NSCs
and regulates NSC migration, but is downregulated during
diﬀerentiation (Iguchi et al., 2008; Bai et al., 2009). Both
cannabinoid (CB) receptors have been reported to play
a role in neural development. Activation of CB2 promotes
NSC proliferation (Molina-Holgado et al., 2007), whereas
knockout of CB1 in mice results in ineﬀective adult neuro-
genesis (Jin et al., 2004). Alpha-1 adrenergic receptors
stimulation induces the proliferation and migration of
NPCs (Hiramoto et al., 2006), and dopamine D1 receptor
mainly regulates NPC migration (Hiramoto et al., 2008). In
addition, activation of l- and j-opioids improves the per-
centage of ESC-derived RA-induced NPCs (Kim et al.,
2006). In our study, we also found the dramatic changes
in expression levels of GPCRs when hESCs diﬀerentiate
into NSCs, supporting the regulatory roles of GPCRs in
neurogenesis.Chemokines, the most important and best known
group of chemotactic proteins, participate in many
physiological processes, including immunosurveillance
(Chong et al., 2004), immune cell diﬀerentiation (Nieto
et al., 1997), inﬂammation (Koelink et al., 2012), angio-
genesis (Rudolph and Woods, 2005), neurogenesis
(Doze and Perez, 2012) and so on. Chemokines act on
multiple cell targets via their receptors that belong to the
rhodopsin-like receptor family of GPCRs. Chemokine
receptors include CXC chemokine receptors, CC chemo-
kine receptors, CX3C chemokine receptors and XC che-
mokine receptors (Zlotnik and Yoshie, 2000). Among
them, CXCR4 and its ligand SDF-1 are relatively well-
studied mediators involved in human neuronal develop-
ment and play critical roles in human NPC proliferation
and migration (Wu et al., 2009). In consistence with previ-
ous reports (Ni et al., 2004), we conﬁrmed that CXCR4 is
highly expressed in human NSCs. Besides, we observed
a dramatic increase in CXCR4 expression during hESC to
NSC transition. To rule out the possibility that the
increased expression is solely the consequence of neural
diﬀerentiation, we performed the knockdown experi-
ments. Indeed, cells with downregulated CXCR4 is much
harder to be induced to express the NSC marker Nestin,
supporting that CXCR4 is important for neural diﬀerentia-
tion of hESCs. Interestingly, we observed dramatic mor-
phology changes in CXCR4-knockdown hESCs,
although without causing the loss of pluripotent genes,
suggesting CXCR4 may also be important in maintaining
the properties of hESCs. Further cell culture showed diﬃ-
culty in clonal expansion of CXCR4 shRNA transfected
hESCs (data not shown). According to the literatures,
we found that CXCR4 regulates neuron survival via aﬀect-
ing cell-cycle proteins in neurons (Khan et al., 2003), and
CXCR4-mediated endocytotic signaling pathway is
essential to human neural progenitor cell survival (Zhu
et al., 2012). Whether CXCR4 plays an important role in
hESC survival or self-renewal is still unclear and worthy
of further investigation in the future.
Fig. 5. Knockdown of CXCR4 retarded Nestin expression and blocks neural induction of hESCs. (A) Immunoﬂuorescent staining of Nestin on day
3–7 of neural induction (Scale bar = 10 lm). (B) Representative images of cells expressing CXCR4 or scramble shRNA (both with GFP reporter) on
day 6 of neural induction. (Scale bar = 10 lm), cells that are GFP-positive but almost Nestin-negative are cycled with white dashed line. (C)
Statistical analysis of the percent of Nestin-positive area presented in (A). The data are mean ± SEM (n= 10). *P< 0.05, **P< 0.01,
***P< 0.001, versus scramble. (D) Statistical analysis of the percentage of Nestin and GFP double positive cells in shRNA transfected cells (GFP
positive). The data are mean ± SEM (n= 3). **P< 0.01, ***P< 0.001, versus scramble.
L. Zhang et al. / Neuroscience 337 (2016) 88–97 95In addition to CXCR4, we found that CXCR7, a
receptor closely related to CXCR4, and their common
ligand SDF-1 changed dramatically. It was reported that
CXCR7 binds to SDF-1 with higher aﬃnity than CXCR4;
therefore, CXCR7 may function as an antagonizer for
CXCR4 via ligand competition (Naumann et al., 2010).
Kalatskaya et al. found that AMD3100, a known CXCR4
antagonist, increases SDF-1 binding to CXCR7 and
SDF-1-induced conformational rearrangements in the
receptor dimer (Kalatskaya et al., 2009). However,
another study demonstrated that SDF-1 promotes human
NPC survival in the events of camptothecin-induced
apoptosis or growth factor deprivation, which required
both CXCR7 and CXCR4 through CXCR7- andCXCR4-mediated endocytotic signaling (Zhu et al.,
2012). In our study, we saw increased expression of both
receptors during hESC to NSC transition and we con-
ﬁrmed that adding SDF-1 in the culture medium promotes
the transition and CXCR4 is indispensible for such a pro-
cess. Since CXCR7 expression also increased signiﬁ-
cantly, whether CXCR7 is also required as a coregulator
for the transition needs to be further investigated.
Besides, we saw a decreased expression of SDF-1 in
NSCs compared to hESCs. It has been reported that
the spatial and cellular expression patterns of SDF-1
and CXCR4 in the brain are diﬀerent and this diﬀerential
expression of CXCR4 and SDF-1 may be important for
the temporal regulation of neuronal migration and circuit
Fig. 6. Knockdown of CXCR4 retarded Sox1 expression and blocks neural induction of hESCs. (A) Immunoﬂuorescent staining of Sox1 on day 3–7
of neural induction (Scale bar = 10 lm). (B) Representative images of cells expressing CXCR4 or scramble shRNA (both with GFP reporter) on day
7 of neural induction. Cells that are GFP-positive but almost Sox1-negative are cycled with white dashed line. (Scale bar = 10 lm). (C) Statistical
analysis of the percent of Sox1-positive cells presented in (A). The data are mean ± SEM (n= 10). **P< 0.01, ***P< 0.001, versus scramble. (D)
Statistical analysis of the percentage of Sox-1 and GFP double-positive cells in shRNA transfected cells (GFP positive). The data are mean ± SEM
(n= 3). ***P< 0.001, versus scramble.
96 L. Zhang et al. / Neuroscience 337 (2016) 88–97formation during development and possibly in adult
neurogenesis and repair (Peng et al., 2007). Therefore,
during hESC neural diﬀerentiation, the diﬀerent expres-
sion pattern of CXCR4 and SDF-1 can be considered as
a way to fulﬁll their distinct temporal and spatial functions.
Taken together, we found that CXCR4 plays an
important role in hESC neural induction process and
activation of CXCR4 promotes hESC to NSC transition.
Therefore, CXCR4 might be considered as a promising
target in regenerative medicine to facilitate eﬃcient NSC
production from hESCs.
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